Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Enterprise Value: 2012-2025

Historic Enterprise Value for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $811.6 million.

  • CorMedix's Enterprise Value rose 100.23% to $811.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $491.7 million, marking a year-over-year increase of 129.15%. This contributed to the annual value of $439.8 million for FY2024, which is 113.40% up from last year.
  • CorMedix's Enterprise Value amounted to $811.6 million in Q3 2025, which was up 25.85% from $644.9 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Enterprise Value peaked at $811.6 million during Q3 2025, and registered a low of $57.3 million during Q3 2022.
  • Its 3-year average for Enterprise Value is $342.9 million, with a median of $281.4 million in 2024.
  • Its Enterprise Value has fluctuated over the past 5 years, first spiked by 323.03% in 2021, then slumped by 49.60% in 2022.
  • Quarterly analysis of 5 years shows CorMedix's Enterprise Value stood at $149.1 million in 2021, then fell by 15.86% to $125.4 million in 2022, then spiked by 102.62% to $116.2 million in 2023, then surged by 248.83% to $439.8 million in 2024, then soared by 100.23% to $811.6 million in 2025.
  • Its Enterprise Value stands at $811.6 million for Q3 2025, versus $644.9 million for Q2 2025 and $324.0 million for Q1 2025.